Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...
Hosted on MSN8h
William Blair Initiates Coverage of Altimmune (ALT) with Market Perform RecommendationFintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...
18h
Piper Sandler analyst Yasmeen Rahimi initiated coverage on Avalo Therapeutics, Inc. AVTX with an Overweight rating and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback